In Vitro Toxicity Testing Market by Type (Absorption, Toxic Substances, and Dose), End Users (Cosmetics and Household Products, Pharmaceutical Industry, Food Industry, and Chemical Industry) - Global Opportunity Analysis and Industry Forecast, 2014–2022
- ALL892520
- 110 Pages
- December 2016
- Diagnostic and Biotech
Testing for presence of toxic compounds is an important step during development of new products such as drugs, cosmetics, and food additives, which can save both time and developmental costs as well as reduce the probability of failure during later stages. In vitro toxicity testing is a procedure that helps examine the presence of these toxic compounds over an isolated part of the organism.
The global in vitro toxicity testing market size is estimated to be $2,921 million in 2015 and expected to reach $7,813 million registering a CAGR of 15.07% from 2016 to 2022. The growth of in vitro toxicity testing market is attributed to the increase in number of R&D procedures, which require in vitro testing, ban on animal testing, and increase in awareness about the environmental concerns. However, factors such as reduction in adoption rate and incapability of in vitro models to determine autoimmunity and immunostimulation can hinder the market growth.
The key players profiled in this report include Agilent Technologies, Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International, Inc., General Electric Company, Covance, Inc., Catalent, Inc., Eurofins Scientific, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc.
KEY MARKET BENEFITS:
- The global in vitro toxicity testing market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
- The market estimations from 2014 to 2022 are based on high-end analysis of the key developments.
- The market scenario is comprehensively analyzed with respect to the type, end users, and geography.
- Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
- In-depth analysis, based on geography provides an understanding of the regional market, which assists in strategic business planning.
- Key market players within the global in vitro toxicity testing market are profiled in this report and their strategies are analyzed thoroughly.
KEY MARKET SEGMENTS:
By Type
- Absorption
- Toxic Substances
- Dose
By End Users
- Cosmetics and Household Products
- Pharmaceutical Industry
- Food Industry
- Chemical Industry
By Geography
- North America
- Europe
- Asia-Pacific
- LAMEA
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key Findings
3.2.1 Top impacting factor
3.2.2 Top winning strategies
3.2.3 Top investment pockets
3.3 Value chain analysis
3.4 Porters five forces analysis
3.4.1 Low bargaining power of suppliers due to large number of suppliers and low switching cost
3.4.2 Moderate bargaining power of buyer due to high dem and, high product dependency and low switching cost
3.4.3 Moderate threat of substitutes due to less product differentiation and minimum ease of substitution
3.4.4 Moderate threat of substitutes due to increasing legal barriers, implementation of government policies and high dem and potential
3.4.5 Presence of numerous players, moderate product innovation and low switching cost increases the competition among rivalries
3.5 Drivers
3.5.1 Increased awareness of regulatory authorities concerning environment welfare
3.5.2 Replacement of in-vivo models by in-vitro models
3.5.3 Dem and of in-vitro methods for cancer diagnosis
3.5.4 Increase in global illicit drug abusers
3.6 RESTRAINTS
3.6.1 Reduction in adoption rate of in-vitro toxicity testing methods
3.6.2 Incapability of in vitro models to determine autoimmunity and immunostimulation
3.7 OPPORTUNITIES
3.7.1 Advancement in in-vitro technologies
3.7.2 Development of new in-vitro models
Chapter: 4 WORLD IVTT MARKET, BY TYPE
4.1 Overview
4.2 Absorption
4.2.1 Key Market Trends
4.2.2 Key Growth Factors and Opportunities
4.2.3 Market Size and Forecast
4.2.4 North America Absorption Market, ($Million), Growth (%) 2014-2022
4.2.5 Europe Absorption Market, ($Million), Growth (%) 2014-2022
4.2.6 Asia-pacific Absorption Market, ($Million), Growth (%) 2014-2022
4.2.7 LAMEA Absorption Market, ($Million), Growth (%) 2014-2022
4.3 Toxic substances
4.3.1 Key Market Trends
4.3.2 Key Growth Factors and Opportunities
4.3.3 Market Size and Forecast
4.3.4 North America Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.5 Europe Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.6 Asia Pacific Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.3.7 LAMEA Toxic Substances Market, ($Million), Growth (%) 2014-2022
4.4 Dose
4.4.1 Key Market Trends
4.4.2 Key Growth Factors and Opportunities
4.4.3 Market Size and Forecast
4.4.4 North America Dose Market, ($Million), Growth (%) 2014-2022
4.4.5 Europe Dose Market, ($Million), Growth (%) 2014-2022
4.4.6 Asia Pacific Dose Market, ($Million), Growth (%) 2014-2022
4.4.7 LAMEA Dose Market, ($Million), Growth (%) 2014-2022
Chapter: 5 WORLD IVTT MARKET, BY END USER
5.1 Overview
5.2 Cosmetics and Household products
5.2.1 Key Market Trends
5.2.2 Key Growth Factors and Opportunities
5.2.3 Market Size and Forecast
5.2.4 North America Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.5 Europe Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.6 Asia Pacific Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.2.7 LAMEA Cosmetics and Household Products Market, ($Million), Growth (%) 2014-2022
5.3 Pharmaceutical industry
5.3.1 Key Market Trends
5.3.2 Key Growth Factors and Opportunities
5.3.3 Market Size and Forecast
5.3.4 North America Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.5 Europe Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.6 Asia Pacific Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.3.7 LAMEA Pharmaceutical Industry Market, ($Million), Growth (%) 2014-2022
5.4 Food industry
5.4.1 Key Market Trends
5.4.2 Key Growth Factors and Opportunities
5.4.3 Market Size and Forecast
5.4.4 North America Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.5 Europe Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.6 Asia-pacific Food Industry Market, ($Million), Growth (%) 2014-2022
5.4.7 LAMEA Food Industry Market, ($Million), Growth (%) 2014-2022
5.5 Chemical industry
5.5.1 Key Market Trends
5.5.2 Key Growth Factors and Opportunities
5.5.3 Market Size and Forecast
5.5.4 North America Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.5 Europe Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.6 Asia Pacific Chemical Industry Market, ($Million), Growth (%) 2014-2022
5.5.7 LAMEA Chemical Industry Market, ($Million), Growth (%) 2014-2022
Chapter: 6 WORLD IVTT MARKET BY GEOGRAPHY
6.1 Overview
6.2 North America
6.2.1 Key Market Trends
6.2.2 Key Growth Factors and Opportunities
6.2.3 Market Size and Forecast
6.3 Europe
6.3.1 Key Market Trends
6.3.2 Key Growth Factors and Opportunities
6.3.3 Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Key Market Trends
6.4.2 Key Growth Factors and Opportunities
6.4.3 Market Size and Forecast
6.5 LAMEA
6.5.1 Key Market Trends
6.5.2 Key Growth Factors and Opportunities
6.5.3 Market Size and Forecast
Chapter: 7 COMPANY PROFILES
7.1 Agilent Technologies, Inc.
7.1.1 Company Snapshot
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategies & development
7.2 BioReliance, Inc.
7.2.1 Company Snapshot
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategies & development
7.3 Alere, Inc.
7.3.1 Company Snapshot
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategies & development
7.4 Charles River Laboratories International, Inc.
7.4.1 Company Snapshot
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategies & development
7.5 General Electric Company
7.5.1 Company Snapshot
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategies & development
7.6 Covance, Inc.
7.6.1 Company Snapshot
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategies & development
7.7 Catalent, Inc.
7.7.1 Company Snapshot
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategies & development
7.8 Eurofins Scientific
7.8.1 Company Snapshot
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategies & development
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Company Snapshot
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategies & development
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Company Snapshot
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategies & development
List of Figures
FIG. 1 TOP IMPACTING FACTORS
FIG. 2 TOP INVESTMENT POCKETS
FIG. 3 PORTERS FIVE FORCES ANALYSIS OF IVTT MARKET
FIG. 4 INCREASE NUMBER OF PEOPLE SUFFERING FROM COLON CANCER IN U.S., 2013-16
FIG. 5 WORLD IVTT MARKET BY TYPE, 2015(PIE CHART OF GLOBAL NUMBERS BY TYPE)
FIG. 6 WORLD IVTT MARKET BY END USER, 2015(PIE CHART OF GLOBAL NUMBERS BY END USER)
FIG. 7 WORLD IVTT MARKET BY GEOGRAPHY, 2015
List of Tables
TABLE 1 WORLD ABSORPTION MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 2 NORTH AMERICA ABSORPTION MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 3 EUROPE ABSORPTION MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 4 ASIA PACIFIC ABSORPTION MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 5 LAMEA ABSORPTION MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 6 WORLD TOXIC SUBSTANCES MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 7 NORTH AMERICA TOXIC SUBSTANCES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 8 EUROPE TOXIC SUBSTANCES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 9 ASIA PACIFIC TOXIC SUBSTANCES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 10 LAMEA TOXIC SUBSTANCES MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 11 WORLD DOSE MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 12 NORTH AMERICA DOSE MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 13 EUROPE DOSE MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 14 ASIA PACIFIC DOSE MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 15 LAMEA DOSE MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 16 WORLD COSMETICS and HOUSEHOLD PRODUCTS MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 17 NORTH AMERICA COSMETICS and HOUSEHOLD PRODUCTS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 18 EUROPE COSMETICS and HOUSEHOLD PRODUCTS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 19 ASIA PACIFIC COSMETICS and HOUSEHOLD PRODUCTS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 20 LAMEA COSMETICS and HOUSEHOLD PRODUCTS MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 21 WORLD PHARMACEUTICAL INDUSTRY MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 22 NORTH AMERICA PHARMACEUTICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 23 EUROPE PHARMACEUTICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 24 ASIA PACIFIC PHARMACEUTICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 25 LAMEA PHARMACEUTICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 26 WORLD FOOD INDUSTRY MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 27 NORTH AMERICA FOOD INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 28 EUROPE FOOD INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 29 ASIA PACIFIC FOOD INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 30 LAMEA FOOD INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 31 WORLD CHEMICAL INDUSTRY MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 32 NORTH AMERICA CHEMICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 33 EUROPE CHEMICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 34 ASIA PACIFIC CHEMICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 35 LAMEA CHEMICAL INDUSTRY MARKET, ($MILLION), GROWTH (%) 2014-2022
TABLE 36 NORTH AMERICA IVTT MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 37 EUROPE IVTT MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 38 ASIA-PACIFIC IVTT MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 39 LAMEA IVTT MARKET, ($MILLION), GROWTH (%)2014-2022
TABLE 40 AGILENT TECHNOLOGIES, INC..: COMPANY SNAPSHOT
TABLE 41 AGILENT TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 42 BIORELIANCE, INC.: COMPANY SNAPSHOT
TABLE 43 BIORELIANCE, INC. INC.: OPERATING SEGMENTS
TABLE 44 ALERE, INC.: COMPANY SNAPSHOT
TABLE 45 ALERE, INC.: OPERATING SEGMENTS
TABLE 46 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 47 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS
TABLE 48 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 49 GENERAL ELECTRIC COMPANY OPERATING SEGMENTS
TABLE 50 COVANCE, INC.: COMPANY SNAPSHOT
TABLE 51 COVANCE, INC: OPERATING SEGMENTS
TABLE 52 CATALENT, INC.: COMPANY SNAPSHOT
TABLE 53 CATALENT, INC.: OPERATING SEGMENTS
TABLE 54 EUROFINS SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 55 EUROFINS SCIENTIFIC.: OPERATING SEGMENTS
TABLE 56 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 57 BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 58 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 59 THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
